Brief: EQL Secures Memprex Licence With Partner For Spain
13/07/2026 14:16
BRIEF-EQL Secures Memprex Licence With Partner For Spain July 13 (Reuters) - EQL Pharma AB EQL.ST:
MEMPREX (METHENAMINE HIPPURATE) LICENSE SIGNED WITH PARTNER FOR SPAIN
GEBRO HOLDING GMBH WILL, SUBJECT TO REACHING AGREED SALES, PAY A SIX-FIGURE SUM IN EUR SPREAD OVER SIX MILESTONES
Source text: ID:nWkr1RTy6T
Further company coverage: EQL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))